| Home  | About ScienceAsia  | Publication charge  | Advertise with us  | Subscription for printed version  | Contact us  
Editorial Board
Journal Policy
Instructions for Authors
Online submission
Author Login
Reviewer Login
Volume 50 Number 1
Volume 49 Number 6
Volume 49 Number 5
Volume 49S Number 1
Volume 49 Number 4
Volume 49 Number 3
Earlier issues
Volume  Number 

previous article next article

Research articles

ScienceAsia (): 625-630 |doi: 10.2306/scienceasia1513-1874...625


Association between MYH9 gene polymorphisms and membranous glomerulonephritis patients in Taiwan


Yng-Tay Chena,b, Cheng-Hsu Chenc, Chia-Hung Yend, Shih-Yin Chena,e, Fuu-Jen Tsaia,b,f,g,*

 
ABSTRACT:     Membranous glomerulonephritis (MGN) is a common cause of idiopathic nephrotic syndrome in adults end-stage renal disease in 25% of patients. MYH9 gene polymorphisms have been reported to be associated with several types of renal diseases. The objective of this study was to clarify the relationship between MYH9 gene polymorphisms and the pathogenesis of MGN. We investigated MYH9 gene polymorphisms (rs7078 and rs12107) and their association with MGN susceptibility in 400 Taiwanese individuals (135 MGN patients and 265 healthy controls). The results revealed a statistically significant difference in allele frequency distribution at the rs12107 between MGN patients and the control group (p=0.04). In addition, individuals with the AA genotype at the rs12107 SNP who become MGN patients may have a higher risk of kidney failure than other MGN patients (adjusted odds ratio: 1.63; 95% confidence interval: 1.08–2.48, p=0.02). A C-A haplotype was susceptible for development of MGN. Our data show that MYH9 (rs12107) polymorphism may be the underlying cause of MGN; hence the polymorphism examined in this study warrant further investigation.

Download PDF

4 Downloads 1691 Views

a Department of Medical Research, Genetic Centre, China Medical University Hospital, Taichung, Taiwan
b Department of Biomedical Informatics, Asia University, Taichung, Taiwan
c Department of Internal Medicine, Division of Nephrology, Taichung Veterans General Hospital, Taichung, Taiwan
d Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
e Graduate Institute of Chinese Medical Science, College of Chinese Medicine, China Medical University, Taichung, Taiwan
f Department of Medical Genetics, China Medical University Hospital, Taichung, Taiwan
g Department of Biotechnology, Asia University, Taichung, Taiwan

* Corresponding author, E-mail: d0704@mail.cmuh.org.tw

Received 5 Feb 2013, Accepted 22 Oct 2013